Firebrick Pharma Limited (ASX:FRE)
Australia · Delayed Price · Currency is AUD 0.0520
0.00 (0.00%)
Dec 12, 2025, 3:59 PM AEST
Firebrick Pharma Market Cap
Firebrick Pharma has a market cap or net worth of 13.02 million as of December 15, 2025. Its market cap has increased by 12.78% in one year.
Market Cap
13.02M
Enterprise Value
12.04M
Revenue
515.51K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
Market Cap Chart
Since January 28, 2022, Firebrick Pharma's market cap has decreased from 89.49M to 13.02M, a decrease of -85.45%. That is a compound annual growth rate of -39.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 13.02M | -0.06% |
| Dec 31, 2024 | 13.03M | 46.33% |
| Dec 29, 2023 | 8.90M | -77.12% |
| Dec 29, 2022 | 38.92M | -56.51% |
| Jan 28, 2022 | 89.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 88.73B |
| Pro Medicus | 24.49B |
| Cochlear | 17.23B |
| Sonic Healthcare | 11.46B |
| Ramsay Health Care | 8.16B |
| Ansell | 5.12B |
| Telix Pharmaceuticals | 4.65B |
| Mesoblast | 3.55B |